Category: Thomas Gayner

In his interview, Tom Gayner, CEO of Markel Group, reflects on investment principles shaped by Warren Buffett and Charlie Munger, and offers a detailed assessment of Novo Nordisk. Gayner praises Novo Nordisk for its business quality, global leadership in diabetes treatment, and strong growth trajectory. He credits the company’s disciplined management and innovation in pharmaceuticals as exemplary, aligning with his own standards of long-term value creation.

Tom Gayner and his Markel colleagues had over 2,500 people attending (large brunch!) discussing the Markel business and investment philosophy.

Tom Gayner discusses a number of interesting topics, including how we as investors can improve our decision-making process by using probabilities and the benefits of dollar cost averaging.